Response,Percentage of men enrolled in TT prescription
Hypolipidemics,37%
SSRIs,20.7%
Ace inhibitors,18.1%
NSAIDs,16.3%
Beta blockers,15.5%
Anti-diabetes drugs,15.2%
Other cardiac drugs,13.8%
Corticosteroids,12.7%
Calcium channel blockers,11.7%
Diuretics,10.4%
Insulin,3.9%
Antiplatelets,3.4%
Anti-hypertensive NOS,3.2%
Anticoagulant,2.8%
Vasodialators,2%
